National Strategic Accounts Team Lead
Intellia Therapeutics(1 month ago)
About this role
The National Strategic Accounts Team Lead at Intellia will lead a team of strategic account managers to enable and optimize treatment sites for the company’s CRISPR therapy, overseeing site activation, operational care pathways, and pull‑through of therapy delivery. Reporting to the VP of Sales, the role combines cross‑functional leadership, stakeholder engagement, and strategic planning to drive commercialization of a one‑time gene‑editing treatment.
Required Skills
- Leadership
- Strategy
- Stakeholder Management
- Site Activation
- Collaboration
- Project Management
- Operational Excellence
- Budget Management
- Regulatory Compliance
- Gene Therapy
+1 more
Qualifications
- Bachelor's Degree in Life Sciences, Business, or Healthcare Administration
- MBA
- MPH
- PharmD
About Intellia Therapeutics
intelliatx.comIntellia Therapeutics, a leading clinical-stage genome editing company, is developing novel, potentially curative therapeutics leveraging CRISPR-based technologies.
View more jobs at Intellia Therapeutics →Apply instantly with AI
Let ApplyBlast auto-apply to jobs like this for you. Save hours on applications and land your dream job faster.
More jobs at Intellia Therapeutics
Associate Director Pharmacovigilance Operations
Intellia Therapeutics(7 days ago)
Senior Manager, Supply Chain Logistics and Business Systems
Intellia Therapeutics(13 days ago)
Senior Manager, Commercial Performance and Analytics
Intellia Therapeutics(20 days ago)
Regional Scientific Director, Gulf Region
Intellia Therapeutics(21 days ago)
Similar Jobs
Associate Director of Gene Editing
Alumni Network Job Board(1 month ago)
VP, Head of Key Account Managers
Beam Therapeutics(1 month ago)
Director, Oncology National Accounts
Ferring Uro(1 month ago)
Scientist II/Senior Scientist Nonclinical Development
Epicrispr Biotechnologies(1 month ago)
Director/Sr. Director Regulatory CMC, Lilly Gene Therapy
LI Test Company(1 month ago)
Senior Scientist, LNP MSAT
CRISPR Therapeutics(29 days ago)